IRIS
PURRELLO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.668
EU - Europa 9.134
AS - Asia 8.362
SA - Sud America 1.644
AF - Africa 1.176
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
Totale 37.018
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.098
SG - Singapore 4.313
RU - Federazione Russa 2.763
IT - Italia 2.276
CN - Cina 2.050
BR - Brasile 1.385
IE - Irlanda 1.304
UA - Ucraina 1.028
VN - Vietnam 765
CI - Costa d'Avorio 588
CA - Canada 450
FR - Francia 450
IN - India 317
DE - Germania 274
SE - Svezia 244
GB - Regno Unito 223
NG - Nigeria 205
KR - Corea 203
SN - Senegal 201
NL - Olanda 100
BD - Bangladesh 98
AR - Argentina 87
FI - Finlandia 84
PL - Polonia 83
TR - Turchia 76
HK - Hong Kong 73
JP - Giappone 72
ZA - Sudafrica 71
MX - Messico 69
IQ - Iraq 57
UZ - Uzbekistan 55
CH - Svizzera 44
EC - Ecuador 44
ES - Italia 42
AT - Austria 41
CO - Colombia 39
PK - Pakistan 36
IR - Iran 31
ID - Indonesia 29
GR - Grecia 27
MA - Marocco 27
VE - Venezuela 27
LB - Libano 26
CZ - Repubblica Ceca 22
KE - Kenya 22
CL - Cile 21
SA - Arabia Saudita 21
LT - Lituania 20
AU - Australia 19
BE - Belgio 19
BJ - Benin 14
AZ - Azerbaigian 13
EG - Egitto 13
PY - Paraguay 13
BG - Bulgaria 12
OM - Oman 12
PH - Filippine 12
EU - Europa 11
JO - Giordania 11
PA - Panama 11
RO - Romania 11
UY - Uruguay 11
AL - Albania 10
NP - Nepal 10
TH - Thailandia 10
TN - Tunisia 10
HR - Croazia 9
IL - Israele 9
KZ - Kazakistan 9
PE - Perù 9
JM - Giamaica 8
KW - Kuwait 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
HU - Ungheria 7
KG - Kirghizistan 7
MY - Malesia 7
PS - Palestinian Territory 7
ET - Etiopia 6
RS - Serbia 6
CR - Costa Rica 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GE - Georgia 4
IS - Islanda 4
MK - Macedonia 4
SI - Slovenia 4
SV - El Salvador 4
DK - Danimarca 3
HN - Honduras 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
GD - Grenada 2
Totale 36.978
Salva come PNG Salva come JPEG
Città #
Dallas 2.712
Singapore 2.550
Santa Clara 1.820
Chandler 1.403
Dublin 1.297
Moscow 1.131
San Jose 1.075
Jacksonville 1.067
Ashburn 779
Chicago 604
Abidjan 588
Boardman 544
Catania 366
Cambridge 355
Lawrence 354
Andover 347
Lauterbourg 343
Nanjing 341
Beijing 316
Los Angeles 302
Toronto 294
Hefei 292
Ho Chi Minh City 253
Civitanova Marche 252
Wilmington 222
Dakar 201
Seoul 201
Des Moines 188
Rome 179
Kochi 176
Milan 167
San Mateo 167
Hanoi 159
Council Bluffs 154
New York 154
São Paulo 125
Abuja 102
Nanchang 100
Shenyang 95
Buffalo 92
Houston 92
Padova 88
Hebei 86
Palermo 85
Lagos 78
The Dalles 78
Saint Petersburg 72
Ottawa 68
Dong Ket 67
Jiaxing 67
Tokyo 65
Warsaw 64
Columbus 62
Hong Kong 62
Orem 62
Munich 60
Bremen 55
Montreal 54
Changsha 48
Johannesburg 47
Brooklyn 46
Grafing 45
Rio de Janeiro 44
Stockholm 43
Tianjin 43
Denver 40
London 39
Phoenix 39
Amsterdam 38
Atlanta 37
San Francisco 37
Belo Horizonte 36
Chennai 36
Helsinki 35
Naples 34
Da Nang 33
Seattle 33
Lappeenranta 32
Boston 31
Istanbul 31
Poplar 31
Brasília 30
Frankfurt am Main 26
Tashkent 26
Manchester 25
Messina 23
Port Harcourt 23
Pune 23
Redondo Beach 23
Augusta 22
Washington 22
Kunming 21
Den Haag 20
Mexico City 20
Shanghai 20
Boydton 19
Carrara 19
Dhaka 19
Haiphong 19
Nairobi 19
Totale 24.429
Salva come PNG Salva come JPEG
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 716
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 386
Il Rasario. Semeiotica medica 271
Criteri IDF e ATP-III per la diagnosi di sindrome metabolica: relazione con la prevalenza di steatosi epatica 268
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 261
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 221
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 205
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 201
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 191
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 183
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 176
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 173
A ten-year (1989-1998) perspective study of the incidence of Type 1 diabetes in the district of Catania (Sicily) in a 0-14 year age group 169
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 166
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 165
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 164
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 162
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 161
COPPER ADDITION PREVENTS THE INHIBITORY EFFECTS OF INTERLEUKIN-1-BETA ON RAT PANCREATIC-ISLETS 159
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 159
Antibiotic use and associated factors in a large sample of hospitalised older people 158
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 154
Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance 154
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 153
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 151
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 150
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 150
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 149
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 149
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 148
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 147
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma 147
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 147
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 147
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 146
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 146
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 144
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 143
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 143
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 143
Clinical and molecular biomarkers for diagnosis and staging of nafld 142
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 141
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 141
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 140
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 140
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 139
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 139
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 138
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 138
Heart failure and chronic kidney disease in a registry of internal medicine wards 138
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 138
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 137
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 136
Action of insulin at the nuclear envelope 136
Smoking and diabetes: Dangerous liaisons and confusing relationships 136
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 136
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 136
Alterazioni della funzione diastolica in pazienti con diabete tipo 2 neodiagnosticato 135
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 135
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 133
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 132
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 132
Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1β. Possible involvement of K+ and Ca2+ channels 131
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 130
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 130
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 130
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 128
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 128
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 128
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 127
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 126
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 126
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 125
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 125
Transient impairment of thyroid function in newborn from an area of endemic goiter 124
Anticorpi anti-GH in soggetti in trattamento con ormone della crescita: incidenza e possibile ruolo degli aggregati dell'ormone nella loro genesi 124
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 124
Correlazione fra patologia tiroidea e presenza di anticorpi antitireoglobulina ed antimicrosomi tiroidei 123
Glucose regulates both glucose transport and the glucose transporter gene expression in a hamster-derived pancreatic Beta-cell line (HIT) 122
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 122
ALTERAZIONI DELLA FUNZIONE DIASTOLICA IN PAZIENTI CON DIABETE DI TIPO 2 NEODIAGNOSTICATO 122
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 121
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 121
L’analogo dell’insulina Lispro riduce i picchi iperglicemici post-prandiali in soggetti con diabete tipo 2 121
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 121
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 121
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 120
Early effects of high-fat diet, extra-virgin olive oil and vitamin D in a sedentary rat model of non-alcoholic fatty liver disease. 120
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 119
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 118
.:FATTORI PROGNOSTICI DI GUARIGIONE DELLE ULCERE DEL PIEDE DIABETICO 118
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 118
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets 117
Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms 116
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 116
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 116
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 116
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 115
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 115
Correction: Smoking and diabetes: dangerous liaisons and confusing relationships 114
Totale 15.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021433 0 0 0 0 0 0 0 0 0 0 288 145
2021/20222.656 289 362 17 66 427 58 377 102 218 11 103 626
2022/20234.336 386 200 65 417 406 742 23 802 1.023 30 149 93
2023/20242.049 110 308 103 116 86 440 39 169 23 63 341 251
2024/20258.501 736 1.188 466 499 1.607 852 294 272 520 760 758 549
2025/202615.450 924 693 3.023 1.085 2.428 3.085 1.949 345 789 879 250 0
Totale 37.638